TY - GEN
T1 - A combined differential evolution and NSGA-II approach for parametric optimization of a cancer immunotherapy model
AU - Xu, Weinan
AU - Xu, Jianxin
AU - He, Danhua
AU - Tan, Kay Chen
N1 - Publisher Copyright:
© 2017 IEEE.
PY - 2018/2/2
Y1 - 2018/2/2
N2 - According to the clinical results from Manrique et. al. [1], a breast cancer immunotherapy model is established. The model is established based on biological principles and limited clinical results [1] for replications and prognostics of therapeutic effects. A single objective parametric optimization problem is formulated to find appropriate parameter values with biological meanings. Several constraints are formulated to satisfy both the disease progression without treatments and bio-system stability and equilibrium. To solve this parametric optimization problem with constraints automatically, the ϵ-DE+NSGA-II algorithm is proposed. The constraint violation is the second objective to be optimized in NSGA-II. The proposed ϵ-DE+NSGA-II can find the optimal parameters of the cancer immunotherapy model. The cancer immunotherapy model with the optimized parameters can not only replicate the clinical results from [1], but also provide prognostic outcomes for tumor rejection under various drug delivery schedules.
AB - According to the clinical results from Manrique et. al. [1], a breast cancer immunotherapy model is established. The model is established based on biological principles and limited clinical results [1] for replications and prognostics of therapeutic effects. A single objective parametric optimization problem is formulated to find appropriate parameter values with biological meanings. Several constraints are formulated to satisfy both the disease progression without treatments and bio-system stability and equilibrium. To solve this parametric optimization problem with constraints automatically, the ϵ-DE+NSGA-II algorithm is proposed. The constraint violation is the second objective to be optimized in NSGA-II. The proposed ϵ-DE+NSGA-II can find the optimal parameters of the cancer immunotherapy model. The cancer immunotherapy model with the optimized parameters can not only replicate the clinical results from [1], but also provide prognostic outcomes for tumor rejection under various drug delivery schedules.
UR - http://www.scopus.com/inward/record.url?scp=85046084405&partnerID=8YFLogxK
U2 - 10.1109/SSCI.2017.8285259
DO - 10.1109/SSCI.2017.8285259
M3 - Conference article published in proceeding or book
AN - SCOPUS:85046084405
T3 - 2017 IEEE Symposium Series on Computational Intelligence, SSCI 2017 - Proceedings
SP - 1
EP - 8
BT - 2017 IEEE Symposium Series on Computational Intelligence, SSCI 2017 - Proceedings
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 2017 IEEE Symposium Series on Computational Intelligence, SSCI 2017
Y2 - 27 November 2017 through 1 December 2017
ER -